Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species
暂无分享,去创建一个
D. Cui | Mutsuo Takahashi | T. Gondo | Y. Hoshii | T. Ishihara | H. Kawano | M. Setoguchi | Dan Cui | Hiroo Kawano | Mutsuo Takahashi | Yoshinobu Hoshii | Mihoko Setoguchi | Toshikazu Gondo | Tokuhiro Ishihara
[1] T. Chiba,et al. Transmission of Mouse Senile Amyloidosis , 2001, Laboratory Investigation.
[2] M. Skinner,et al. Murine amyloid protein AA in casein-induced experimental amyloidosis. , 1977, Laboratory investigation; a journal of technical methods and pathology.
[3] 星井 嘉信. Immunohistochemical classification of 140 autopsy cases with systemic amyloidosis , 1994 .
[4] T. Niewold,et al. Fibril Amyloid Enhancing Factor (FAEF)‐Accelerated Amyloidosis in the Hamster is Not Dependent on Serine Esterase Activity and Mononuclear Phagocytosis , 1991, Scandinavian journal of immunology.
[5] R. Kisilevsky,et al. Sulfated glycosaminoglycans: a common constituent of all amyloids? , 1987, Laboratory investigation; a journal of technical methods and pathology.
[6] M. Obana,et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. , 1994, The Journal of rheumatology.
[7] G. Glenner,et al. The 1990 Guidelines for Nomenclature and Classification of Amyloid and Amyloidosis , 1991 .
[8] A. Cohen,et al. SECONDARY AMYLOIDOSIS IN LEPROMATOUS LEPROSY. POSSIBLE RELATIONSHIPS OF DIET AND ENVIRONMENT. , 1965, Annals of internal medicine.
[9] P. Fraser,et al. New clothes for amyloid enhancing factor (AEF): silk as AEF. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[10] J. Buxbaum,et al. The systemic amyloidoses. , 1998, The New England journal of medicine.
[11] P. Westermark,et al. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. , 1994, Biochemical and biophysical research communications.
[12] T. Blundell,et al. Structure of pentameric human serum amyloid P component , 1994, Nature.
[13] Mutsuo Takahashi,et al. Amyloid enhancing factor (AEF) in the aging mouse , 2004, Virchows Archiv A.
[14] W. Zschiesche,et al. Pathology of animal amyloidoses. , 1989, Pharmacology & therapeutics.
[15] M. Pras,et al. The characterization of soluble amyloid prepared in water. , 1968, The Journal of clinical investigation.
[16] E. Cathcart,et al. Amyloid enhancing factor and dietary transmission in accelerated amyloid A amyloidosis. , 1998, Clinical immunology and immunopathology.
[17] G. Glenner,et al. Amyloid. 3. A method for rapid induction of amyloidosis in mice. , 1968, International archives of allergy and applied immunology.
[18] P. Westermark,et al. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] Thomas Wisniewski,et al. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.
[20] J. Sipe,et al. Biochemical evidence for the biphasic development of experimental amyloidosis. , 1978, Laboratory investigation; a journal of technical methods and pathology.
[21] T. Ishihara,et al. An immunohistochemical study of amyloid P component, apolipoprotein E and ubiquitin in human and murine amyloidoses , 1998, Pathology international.
[22] S. Cousens,et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.
[23] Andrew F. Hill,et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.
[24] Y. Kim,et al. A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[25] M. Skinner,et al. Further characterization of amyloid-enhancing factor. , 1982, Laboratory investigation; a journal of technical methods and pathology.